Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Bejar

Showing results (31-40 of 103) with videos related to

Pageof 11
Sort By:
Blood Advances|October 5, 2019
DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromesBrian Reilly, Tiffany N Tanaka, Dinh Diep, et al.
Blood|May 2, 2015
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromesDavid P Steensma, Rafael Bejar, Siddhartha Jaiswal, et al.
Journal of Patient-Reported Outcomes|July 20, 2021
Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30Antoine Regnault, Farrah Pompilus, Anna Ciesluk, et al.
British Journal of Haematology|August 23, 2018
JAK2 double minutes with resultant simultaneous amplification of JAK2 and CD274 in a therapy-related myelodysplastic syndrome evolving into an acute myeloid leukaemiaHuan-You Wang, Marie L Dell'Aquila, Zeljko Dvanajscak, et al.
Journal of Patient-Reported Outcomes|June 21, 2019
A pragmatic patient-reported outcome strategy for rare disease clinical trials: application of the EORTC item library to myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemiaJill A Bell, Aaron Galaznik, Farrah Pompilus, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Droplet Hi-C for Fast and Scalable Profiling of Chromatin Architecture in Single CellsLei Chang, Yang Xie, Brett Taylor, et al.
The New England Journal of Medicine|July 1, 2011
Clinical effect of point mutations in myelodysplastic syndromesRafael Bejar, Kristen Stevenson, Omar Abdel-Wahab, et al.
Cytotherapy|December 6, 2020
Adoptive transfer of neoantigen-specific T-cell therapy is feasible in older patients with higher-risk myelodysplastic syndromeTiffany N Tanaka, Valentina Ferrari, Alison Tarke, et al.
Cancer Discovery|May 16, 2019
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to LeukemiaEmmalee R Adelman, Hsuan-Ting Huang, Alejandro Roisman, et al.
Molecular and Cellular Biology|February 4, 2009
MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genesSadakatsu Ikeda, Aibin He, Sek Won Kong, et al.
Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
Blood Advances|October 5, 2019
DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromesBrian Reilly, Tiffany N Tanaka, Dinh Diep, et al.
Blood|May 2, 2015
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromesDavid P Steensma, Rafael Bejar, Siddhartha Jaiswal, et al.
Journal of Patient-Reported Outcomes|July 20, 2021
Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30Antoine Regnault, Farrah Pompilus, Anna Ciesluk, et al.
British Journal of Haematology|August 23, 2018
JAK2 double minutes with resultant simultaneous amplification of JAK2 and CD274 in a therapy-related myelodysplastic syndrome evolving into an acute myeloid leukaemiaHuan-You Wang, Marie L Dell'Aquila, Zeljko Dvanajscak, et al.
Journal of Patient-Reported Outcomes|June 21, 2019
A pragmatic patient-reported outcome strategy for rare disease clinical trials: application of the EORTC item library to myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemiaJill A Bell, Aaron Galaznik, Farrah Pompilus, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Droplet Hi-C for Fast and Scalable Profiling of Chromatin Architecture in Single CellsLei Chang, Yang Xie, Brett Taylor, et al.
The New England Journal of Medicine|July 1, 2011
Clinical effect of point mutations in myelodysplastic syndromesRafael Bejar, Kristen Stevenson, Omar Abdel-Wahab, et al.
Cytotherapy|December 6, 2020
Adoptive transfer of neoantigen-specific T-cell therapy is feasible in older patients with higher-risk myelodysplastic syndromeTiffany N Tanaka, Valentina Ferrari, Alison Tarke, et al.
Cancer Discovery|May 16, 2019
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to LeukemiaEmmalee R Adelman, Hsuan-Ting Huang, Alejandro Roisman, et al.
Molecular and Cellular Biology|February 4, 2009
MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genesSadakatsu Ikeda, Aibin He, Sek Won Kong, et al.
Pageof 11